Cargando…

Cerebrospinal fluid metabolomics identifies 19 brain-related phenotype associations

The study of metabolomics and disease has enabled the discovery of new risk factors, diagnostic markers, and drug targets. For neurological and psychiatric phenotypes, the cerebrospinal fluid (CSF) is of particular importance. However, the CSF metabolome is difficult to study on a large scale due to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Panyard, Daniel J., Kim, Kyeong Mo, Darst, Burcu F., Deming, Yuetiva K., Zhong, Xiaoyuan, Wu, Yuchang, Kang, Hyunseung, Carlsson, Cynthia M., Johnson, Sterling C., Asthana, Sanjay, Engelman, Corinne D., Lu, Qiongshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7803963/ https://www.ncbi.nlm.nih.gov/pubmed/33437055 http://dx.doi.org/10.1038/s42003-020-01583-z

Ejemplares similares

CSF metabolites associate with CSF tau and improve prediction of Alzheimer's disease status
por: Dong, Ruocheng, et al.
Publicado: (2021)

CSF metabolites associated with biomarkers of Alzheimer’s disease pathology
por: Dong, Ruocheng, et al.
Publicado: (2023)

Apolipoprotein E moderates the association between Non-APOE Polygenic Risk Score for Alzheimer’s Disease and Aging on Preclinical Cognitive Function
por: Xu, Yuexuan, et al.
Publicado: (2023)

Longitudinal plasma metabolomics of aging and sex
por: Darst, Burcu F., et al.
Publicado: (2019)

The gut microbiota-derived metabolite trimethylamine N-oxide is elevated in Alzheimer’s disease
por: Vogt, Nicholas M., et al.
Publicado: (2018)

Macrovascular and microvascular cerebral blood flow in adults at risk for Alzheimer's disease
por: Clark, Lindsay R., et al.
Publicado: (2017)

Effect of Pathway-specific Polygenic Risk Scores for Alzheimer’s Disease (AD) on Rate of Change in Cognitive Function and AD-related Biomarkers among Asymptomatic Individuals
por: Xu, Yuexuan, et al.
Publicado: (2023)

Transmission and decorrelation methods for detecting rare variants using sequencing data from related individuals
por: Darst, Burcu F., et al.
Publicado: (2016)

Assessing the Biological Mechanisms Linking Smoking Behavior and Cognitive Function: A Mediation Analysis of Untargeted Metabolomics
por: Choi, Jerome J., et al.
Publicado: (2023)

Using recursive feature elimination in random forest to account for correlated variables in high dimensional data
por: Darst, Burcu F., et al.
Publicado: (2018)

Data mining and machine learning approaches for the integration of genome-wide association and methylation data: methodology and main conclusions from GAW20
por: Darst, Burcu, et al.
Publicado: (2018)

In-depth Site-specific Analysis of N-glycoproteome in Human Cerebrospinal Fluid and Glycosylation Landscape Changes in Alzheimer's Disease
por: Chen, Zhengwei, et al.
Publicado: (2021)

Cerebrospinal fluid biomarkers of neurofibrillary tangles and synaptic dysfunction are associated with longitudinal decline in white matter connectivity: A multi-resolution graph analysis
por: Kim, Won Hwa, et al.
Publicado: (2018)

Prioritization of family member sequencing for the detection of rare variants
por: Sippy, Rachel, et al.
Publicado: (2016)

Metabolomics of Cerebrospinal Fluid from Healthy Subjects Reveal Metabolites Associated with Ageing
por: Carlsson, Henrik, et al.
Publicado: (2021)

Genome-wide association study for variants that modulate relationships between cerebrospinal fluid amyloid-beta 42, tau, and p-tau levels
por: Maxwell, Taylor J., et al.
Publicado: (2018)

Measurement batch differences and between‐batch conversion of Alzheimer's disease cerebrospinal fluid biomarker values
por: Ma, Yue, et al.
Publicado: (2021)

Cerebrospinal fluid ratios with Aβ(42) predict preclinical brain β-amyloid accumulation
por: Racine, Annie M., et al.
Publicado: (2015)

Metabolomic investigations in cerebrospinal fluid of Parkinson's disease
por: Willkommen, Desiree, et al.
Publicado: (2018)

Prevalence and Clinical Implications of a β-Amyloid–Negative, Tau-Positive Cerebrospinal Fluid Biomarker Profile in Alzheimer Disease
por: Erickson, Pontus, et al.
Publicado: (2023)

Carrier frequency estimation of Zellweger spectrum disorder using ExAC database and bioinformatics tools
por: Vasiljevic, Eva, et al.
Publicado: (2019)

The metabolomics of human aging: Advances, challenges, and opportunities
por: Panyard, Daniel J., et al.
Publicado: (2022)

Confirmation of neurometabolic diagnoses using age‐dependent cerebrospinal fluid metabolomic profiles
por: Peters, Tessa M. A., et al.
Publicado: (2020)

The longitudinal cerebrospinal fluid metabolomic profile of amyotrophic lateral sclerosis
por: Gray, Elizabeth, et al.
Publicado: (2015)

Cerebrospinal Fluid Metabolome in Parkinson’s Disease and Multiple System Atrophy
por: Kwon, Do Hyeon, et al.
Publicado: (2022)

Comparative Evaluation of MS-based Metabolomics Software and Its Application to Preclinical Alzheimer’s Disease
por: Hao, Ling, et al.
Publicado: (2018)

Exploring common genetic contributors to neuroprotection from amyloid pathology
por: Seto, Mabel, et al.
Publicado: (2022)

A Strategy for Discovery and Verification of Candidate Biomarkers in Cerebrospinal Fluid of Preclinical Alzheimer’s Disease
por: Zhong, Xiaofang, et al.
Publicado: (2019)

Impact of Nitisinone on the Cerebrospinal Fluid Metabolome of a Murine Model of Alkaptonuria
por: Davison, Andrew S., et al.
Publicado: (2022)

Day–night fluctuations in choroid plexus transcriptomics and cerebrospinal fluid metabolomics
por: Edelbo, Beatriche Louise, et al.
Publicado: (2023)

Metabolomics of cerebrospinal fluid reveals prognostic biomarkers in pediatric status epilepticus
por: Wang, Tianqi, et al.
Publicado: (2023)

Unique genetic architecture of CSF and brain metabolites pinpoints the novel targets for the traits of human wellness
por: Wang, Ciyang, et al.
Publicado: (2023)

AD‐associated CSF biomolecular changes are attenuated in KL‐VS heterozygotes
por: Driscoll, Ira, et al.
Publicado: (2022)

Biomarker discovery in human cerebrospinal fluid: the need for integrative metabolome and proteome databases
por: Schwarz, Emanuel, et al.
Publicado: (2012)

NMR metabolomics of cerebrospinal fluid differentiates inflammatory diseases of the central nervous system
por: French, Caitlin D., et al.
Publicado: (2018)

Metabolite Profiles of the Cerebrospinal Fluid in Neurosyphilis Patients Determined by Untargeted Metabolomics Analysis
por: Liu, Li-Li, et al.
Publicado: (2019)

Time Course of Metabolomic Alterations in Cerebrospinal Fluid After Aneurysmal Subarachnoid Hemorrhage
por: Ho, Wing Mann, et al.
Publicado: (2020)

Targeted metabolomic profiling of cerebrospinal fluid from patients with progressive multifocal leukoencephalopathy
por: Luo, Yi, et al.
Publicado: (2020)

Cerebrospinal fluid metabolomics: detection of neuroinflammation in human central nervous system disease
por: Yan, Jingya, et al.
Publicado: (2021)

Identification of cerebrospinal fluid and serum metabolomic biomarkers in first episode psychosis patients
por: Shang, Pei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_trs5jkh7lhivser5d7fotv3j9m